Introduction
Ultraviolet radiation emitted by the sun is not only capable of serving as a major carcinogen (both as initiator and promoter) for most skin cancers, but UVlight also contributes to the aging process of skin Campisi, 1998; Yaar and Gilchrest, 1998) . Pro-carcinogenic eects of UV-light may be blocked by three distinct, but potentially interrelated cellular responses involving epidermal keratinocytes (KCs); namely, DNA repair, apoptosis, and senescence. One of the most widely studied responses to UV-light is for DNA-damaged KCs to be eliminated via apoptosis ± a process referred to as a cellular proofreading Meek, 1998) . The primary mediator responsible for removing DNA damaged keratinocytes in skin is believed to be p53, and this so-called`guardian of the tissue' role for p53 has dominated the ®eld of cutaneous carcinogenesis for the past several decades (Ananthaswamy et al., 1997; Burren et al., 1998; Cleaver, 1968; Gniadecki et al., 1997; Hall et al., 1993; Jonason et al., 1996; Levine, 1997; Li et al., 1996 Li et al., , 1998 Nakazawa et al., 1994; Ponten et al., 2001; Rees, 1995; Wolf et al., 1995; Ziegler et al., 1994) . While many reports using rodent models are in line with a role for p53 in UV-induced apoptosis of KCs (ibid), the precise functional role for p53 in human skin remains to be clari®ed (Dazard et al., 2000; Kulms et al., 1999; Li et al., 1996; Spandau, 1994; Terui et al., 2001) . This study was undertaken to further explore the pattern of p53 expression in UVirradiated human epidermis, and delineate the role for p53 in the subsequent apoptotic response, using both normal human skin maintained in short term organ cultures and living human epidermal equivalents.
An additional process that may counteract the carcinogenic eects of UV-light in skin, is for KCs to enter a biological state resembling cellular senescence (Nickolo, 2001) . The senescence response, while not eliminating potentially oncogenic KCs as does the apoptotic response, does trigger irreversible growth arrest which can achieve the same fail-safe result of preventing proliferation necessary for the transformation process (Campisi, 2000; Sager, 1991; Yeager et al., 1998) . In ®broblasts, not only does p53 regulate apoptosis, but it also regulates senescence (Itahana et al., 2001) . Since a role for p53 in KC senescence has not been de®ned, we explored whether p53 is also involved in KCs that have undergone replicative senescence. Moreover, the p53-related studies were extended beyond normal skin to include psoriasis, because KCs derived from psoriatic plaques have the intriguing phenotype of being simultaneously resistant to UV-induced apoptosis, (Wrone-Smith et al., 1997) but also are resistant to transformation (Nickolo, 2001) . We postulated that psoriatic KCs undergo a`senescent switch', and the purpose of this current study was to compare/contrast KCs in psoriatic plaques to normal KCs undergoing spontaneous replicative senescence as regards the function of p53. Previous reports demonstrated enhanced levels of p53 in psoriasis, but did not further characterize whether it was phosphorylated or acetylated (Helander et al., 1993; Soini et al., 1994) . A growing body of evidence points to key post-translational modi®cations in p53 that regulate its function (reviewed in Appella and Anderson, 2001) . Since sunlight represents a ubiquitous carcinogen that has been implicated in various skin cancers, de®ning a role for p53 in KCs exposed to UV-light represents an important line of inquiry for photobiologists and cutaneous oncologists (Cleaver and Mitchell, 1996; Stege et al., 2001; Tornaletti et al., 1993) .
Results

Induction and repair of UV-induced DNA thymine dimers in human skin
Initial experiments were designed to characterize the eect of various doses of UV-light with respect to the kinetics for introduction and removal of thymine dimers in DNA of epidermal KCs (Burren et al., 1998) . A short-term whole skin organ culture model system was used so as to preserve the normal tissue microenvironment. This type of approach has been successfully used by others probing the in¯uence of UV-light on cell cycle regulators in normal human skin (Pavey et al., 2001) . To explore onset, intraepidermal location, and disappearance (repair) of thymine dimers induced by UV-light, human skin samples were immunostained to detect nuclei containing thymine dimers (Figure 1 ). Before irradiation, no KCs were positively stained (Figure 1a inset ), but at the earliest time point examined, 2 h after UV-light exposure (100 mJ/cm 2 ), strong and diuse nuclear positivity was observed throughout the epidermis (Figure 1a ). This staining pattern changed with time, such that basal layer KCs became progressively negative at the 8 h time point ( Figure 1b) ; a trend that continued in suprabasal layers after 24 h (Figure 1c) , and 48 h (Figure 1d ). Only relatively rare apoptotic KCs were observed 24 h after UV-light exposure. After 48 h, scattered upper level KCs possessed nuclei with thymine dimers, which included occasional apoptotic KCs. Thus, while some reduction in thymine dimer staining at 24 and 48 h was related to KC apoptosis, DNA repair in viable KCs accounted for the vast majority of changes in the epidermis after UV-light exposure.
In addition to these kinetic studies, the dose dependent increase in relative number of thymine dimers in human skin was evaluated after 2 h to minimize signi®cant DNA repair. The number of KCs containing nuclei with thymine dimers was assessed before and 2 h after exposure of human skin samples to 25, 50, 75, 100 mj/cm 2 and while no thymine dimer positive KCs were present in non-irradiated KCs, there were 770+85; 1946+201; 2824 +411; and 4867+497 positive KCs per linear cm of skin, respectively. Irrespective of the dose of UV-light, KCs throughout virtually all layers of the epidermis were observed to possess damaged DNA (thymine dimers) to varying degrees using this immunohistochemical approach.
Dose effect of single UV-light exposure on p53 and p53 responsive protein and mRNA levels in human skin
To determine the relative biochemical eects of a single dose of UV-light, human skin samples were exposed to either no UV-light, or various amounts of 50, 75 , 100 mJ/cm 2 ) for 8 h. Western blot analysis revealed a dose dependent increase in total p53 levels in isolated epidermis, which went from being barely detectable in non-UV exposed skin, to markedly elevated levels beginning with 25 mJ/cm 2 , and continuing to increase up to a dose of 100 mJ/cm 2 ( Figure 2a ). Densitometric scanning with quantitation of protein levels for p53 relative to the untreated sample were as follows for the UV-light doses of 25, 50, 75, and 100 mJ/cm 2 , respectively: nine-, 15-, 21-, 30-fold. A relatively similar increase in the p53 target gene-p21 was observed (relative fold increases compared to untreated KCs: 10, 22, 22, 28) . Only slight changes in Bax, Bcl-x and Apaf-1 (a transcriptional target for p53; Moroni et al., 2001; Robles et al., 2001) at both protein and mRNA levels were observed in KCs exposed to UV-light between 25 and 100 mJ/cm 2 (Figure 2a ,b). It should be noted that other p53 target genes such as GADD45 were not consistently induced, suggesting selective transcriptional activation in human skin following UV-light induced DNA damage (Figure 2) . Also, c-Fos (a transcription factor) and mcl-1 an antiapoptotic factor (Fukuchi et al., 2001) , mRNA levels were also not in¯uenced by UV-light exposure.
Several studies had demonstrated, the regulation of p53 activity involves multiple mechanisms and modi®cations including phosphorylation (Berg et al., 1996; Dumaz and Meek, 1999; Giaccia and Kastan, 1998; Meek, 1998; Shieh et al., 1997; Unger et al., 1999) . To determine the state of activation for p53, phosphorylation of serine-15 residues was examined 8 h after UVexposure (Figure 2a) . Phosphorylation of serine-15 residues was selected because it was one of the ®rst modi®cations in p53 to be characterized in several cell types (Appella and Anderson, 2001) . Serine-15 phosphorylated levels of p53 were found to be increased, beginning with only a slight increase at the 50 mJ/cm 2 dose (1.5-fold), which became more apparent after the 75 mJ/cm 2 (threefold) and 100 mJ/cm 2 dose (fourfold).
Kinetic study of UV-light (100 mj/cm 2 ) induced p53-related biochemical changes
Having characterized the dose responsiveness in this experimental system, we next explored the kinetics of the biochemical characteristics of human skin after UV-light exposure. Initially as in the dose study, total cellular p53 levels were assessed and found to be signi®cantly increased 2 h (fourfold), 4 h (10-fold), 8 h (15-fold), and 24 h (sevenfold) after exposure of KCs to 100 mJ/cm 2 of UV-light, which returned to baseline levels after 48 h (Figure 3a) . Also, p21 was increased over the same time course at the protein level (6, 24, 18, 20-fold, respectively) and mRNA levels ( Figure  3a,b) . However, p21 protein levels remained detectable after 48 h (eightfold increase). Only slight changes were noted in Bax and Bcl-x levels following UV-light exposure (less than twofold over entire time course); but Apaf-1 protein levels were increased by up to fourfold after 48 h (Figure 3a) . While no phosphorylation of serine 15 was detectable by Western blot analysis in untreated KC cultures, as early as 2 h after exposure to 100 mJ/cm 2 , serine 15 phosphorylation was present (threefold increase); which increased even further after 4 h of UV-exposure (26-fold), peaking at 8 h (42-fold), followed by a decrease after 24 h (ninefold), and being undetectable after 48 h ( Figure  3a) . By contrast, serine 9 phosphorylated p53 was more ). (a) Note the dose-dependent induction of p53, p21, and serine 15 residues of p53, with little or no change in Bax, Bcl-x, and Apaf-1 levels. (b) The only transcript relatively strongly increased after UV-light exposure is p21, with slight to no change in the other transcript levels measured. b-actin used to verify equivalent protein loading, with L-32 and GAPDH used to verify RNA loading rapidly induced, being increased after 2 h (threefold), and returning to baseline levels at 4, 8, 24 and 48 h. No changes in Bak levels were noted by Western blot analysis after UV-light for any dose or time point examined using the aforementioned protein extracts (data not shown). Also, no consistent changes were observed in the mRNA levels for the other individual genes displayed in the RNase protection assay (RPA) ± Figure 3b .
Localization of p53/phosphorylated p53 in KCs before and after UV-light exposure Given the elevated total cellular protein levels of p53 accumulating in epidermal KCs after a single dose of UV-light, immunohistochemical studies were performed to determine which epidermal layers contained KCs with enhanced nuclear p53 levels. Immunostaining of human skin before ( Figure 4i ). This initial response involving p53 in human KCs is similar to a previous report using mouse skin following a single one MED dose of UV-B (Morris et al., 1997) . While there is no detection of serine 6 phosphorylation before or after UV-exposure (Figure 4b ± j), prominent and diuse KC nuclear staining for serine 9 phosphorylated p53 was apparent 2 h after UV-light exposure (Figure 4g Overall, these immunohistochemical localization studies con®rm and extend the Western blot analysis as shown in Figure 3 .
Changes in levels of mediators of apoptosis after UV-light exposure
To explore induction of apoptosis in epidermal KCs following UV-light exposure (100 mJ/cm 2 ), both routine light microscopy, as well as immunostaining was performed using an antibody to detect the activated form of caspase 3 (Figures 5 and 6). As early as 2 h after UV-light exposure, numerous KCs in the basal layer appeared to be undergoing apoptosis (Figure 4 ± arrows indicate apoptotic or`sunburn' cells); and those KCs staining positively for activated caspase 3 ( Figure  5 ). These cells with positive cytoplasmic caspase 3 immunoreactivity also possessed nuclei displaying early signs of apoptosis. After 8 h, occasional KCs in the suprabasal layer displayed cytological features typical of so-called`sunburn' cells with brightly eosinophilic cytoplasm and pyknotic nuclei, which were also positive for activated caspase 3 (Figures 5b, 6b ). Twenty-four hours following UV-light exposure widespread apoptotic KCs were present in mid and upper epidermal levels including numerous activated caspase-3 positively stained KCs (Figures 5c, 6c) . After 48 h, not only did the uppermost KCs continue to stain positively, but numerous KCs located in the basal cell layer became positive for activated caspase 3 and displayed morphological evidence of apoptosis (Figures 5d, 6d) . Determination of the number of KCs per linear cm of human skin before and after increasing amounts of UV-light reveal the following results for 25, 50, 75, and 100 mJ/cm 2 : 44+12; 97+18; 186+29, and 364+49, respectively.
To verify these immunostaining results, a biochemical analysis of proteins extracted from epidermal sheets removed from human skin samples, before and after UV-light exposure was performed. Activation of caspase 3 was noted by the presence of cleavage of the pro-enzyme in skin exposed to UV-light. After 8 h, cleaved caspase 3 fragments were detected using 75 and 100 mJ/cm 2 doses of UV-light; and in the kinetic study using 100 mJ/cm 2 , activated caspase 3 fragments were detected at 8, 24 and 48 h time points (data not shown). These Western blot studies con®rm the immunohistochemical staining results. Under no conditions examined was caspase 8 activation detectable following UV-light exposure (data not shown). As regards other components of the apoptotic machinery, only a slight increase in total Bak levels was seen after UV-light exposure (data not shown), without change in the Bax levels ( Figure 2 ).
Role of p53 in apoptotic response to UV-induced DNA damage
Given the presence of thymine dimers and onset of apoptosis with rapid induction of Apaf-1 and caspase-3 activation, we next sought to determine if p53 was Both serine 15 and serine 9 residues on p53 became phosphorylated after UV exposure, but with dierent kinetics of appearance and disappearance. (b) UV-light induced the presence of Bcl-x, p53 and p21 levels with slight increases in Gadd45, Bax and Bcl-2 mRNA levels. b-actin used to verify equivalent protein loading, with L-32 and GAPDH used to verify RNA loading playing a role for p53 in the apoptotic response. Since the whole skin organ cultures were too thick to allow penetration of chemical inhibitors, we employed thinner epidermal equivalents. These living epidermal equivalents respond in a similar fashion to UV-light and are useful for studies involving chemical inhibitors. Using epidermal equivalents in the absence or presence of PFT, a chemical inhibitor of p53 mediated transcriptional activation (Komarov et al., 1999) , the apoptotic response and biochemical changes were determined. Figure 7 reveals that, pre-incubating epidermal equivalents with PFT, while not directly inhibiting UV-induced induction of p53 itself ( Figure  7a ; a ± c), did reduce the number of activated caspase 3 positive KCs (Figure 7a ; d ± f). Figure 7b reveals that PFT signi®cantly reduced the number of KCs staining positively for activated caspase 3 at 50 and 100 mJ/cm 2 doses of UV-light by over 60% (P50.01 for both doses).
Since caspase 3 was activated without a detectable change in pro-caspase 8, we explored the possible role for caspase 9 since it can by-pass caspase 8 activation to also activate caspase 3 (Soengas et al., 1999) . Figure 8 reveals the degradation of pro-caspase 3 in epidermal equivalents 24 h after exposure to 100 mJ/cm 2 , and this activation of caspase 3 is blocked by preincubation with PFT. Active caspase 9, while being undetectable in nonirradiated equivalents is generated 24 h after exposure to 100 mJ/cm 2 of UV-light. Moreover, preincubation of equivalents with PFT reduced the appearance of active caspase 9. These caspase related results are consistent with the ability of PFT to block p53 activity.
Characterization of proliferating and senescent KCs with comparison between normal skin to psoriatic plaques before and after exposure to apoptotic stimuli Since we previously observed that both senescent human KCs, as well as KCs derived from psoriatic plaques were resistant to induction of apoptosis by various stimuli Wrone-Smith et al., 1995 , 1997 , biochemical studies were undertaken focusing on p53. Figure 9 (upper panels) reveals Western blot analysis comparing and contrasting the dierential biochemical pro®le for p53 (and its modi®ed versions) in proliferating versus senescent KCs. Note the higher constitutive p53 levels and enhancement following exposure to either UV-light or adriamycin (18 h; 1 mg/ml) in the proliferating KCs compared to the senescent KCs. Moreover, it is clear that senescent KCs do not acetylate the lysine 382 residue under these conditions, and only minimally change their levels of serine 15 phosphorylation of p53. . Note the absence of p53 in skin before irradiation (a), and rapid induction of nuclear p53 positive nuclei in KCs throughout epidermis after 2 h (e), and 8 h (i). No increase in serine 6 phosphorylation of p53 was observed after UV-light (b, f, j). Serine 9 phosphorylation of p53 was undetectable prior to irradiation (c), but became strong and diuse positivity for nuclear staining at 2 h (g), which diminished after 8 h (k). Serine 15 phosphorylation of p53 was absent in pre-irradiated skin (d), with a slight increase after 2 h (h), with greater and more diuse nuclear positivity after 8 h (l). Moving from cultured KCs to normal and psoriatic epidermis, the Figure 9 ± right lower panels reveal Western blot analysis in which two dierent skin samples were examined. Psoriatic plaque (PP skin) contains elevated p53 levels compared to normal (NN) skin samples, (con®rming earlier reports; Helander et al., 1993; Soini et al., 1994) , but there is no detectable serine 15 phosphorylation or lysine 382 acetylation of the p53 residues in psoriatic plaques.
Discussion
The role of p53 in the apoptotic response of both normal and malignant cell types has attracted considerable attention during the past decade. To investigate the molecular and cellular response of epidermal KCs following UV-light exposure, we examined the dose, kinetics, and epidermal localization for several p53 related biochemical events using a human skin-based experimental system. We believe these ex-vivo models employed to explore epidermal KC response are valid since changes in p53 observed in this report are similar to in-vivo results obtained by another group examining change in p53 levels in UVlight irradiated normal human skin (Hall et al., 1993) . Not only does the current ®nding con®rm this earlier report, but we extend the ®ndings by focusing not only on the elevation in p53 following UV-light exposure, but de®ning its post-translational modi®cations, its importance in apoptosis, and identifying mediators involved in the apoptotic response. Another group also used whole skin organ cultures to characterize the UV response of KCs as regards cell cycle checkpoint regulators such as p16 (Pavey et al., 2001) .
To preserve cutaneous homeostasis, there must be an on-going delicate balance struck between KC proliferation and cell death so as to ensure terminal dierentiation and corni®cation in an orderly fashion that is coordinated throughout each layer of the epidermis (Nickolo and Denning, 2001) . When the skin is exposed to sunlight, the physiological response to UV-irradiation, involves not only the regulation of eliminating DNA damage to KCs, but also to minimize 
(a) (2 h); (b) (8 h); (c) (24 h); (d) (48 h).
Note the focal apoptotic KCs in the basal layer beginning after 2 h; whereas at 8 h typical sunburn cells appear in midepidermal layers. Twenty-four hours after UV-exposure numerous apoptotic KCs are present in mid and upper levels of epidermis. After 48 h apoptotic KCs are present at the uppermost layers, which are accompanied by apoptotic KCs in the basal layer. Arrows indicate apoptotic KCs changes in barrier function. Thus, it is critically important to understand not only the apoptotic pathway governing UV-induced apoptosis of KCs (Ananthaswamy et al., 1997; Cleaver, 1968; Li et al., 1996; Wolf et al., 1995) , but also to consider alternate non-apoptotic pathways, such as a senescent switch that may be activated so as to prevent or minimize barrier abnormalities (Nickolo, 2001) . Since p53 has been previously linked to the regulation of apoptosis, as well as senescence (Itahana et al., 2001) ; and because p53 has been linked to sunburn and skin cancer (Ziegler et al., 1994) , this study focused on the role of p53 in the response of human skin to acute UV-light exposure. While numerous such studies have been performed in rodents, there is a paucity of data related to the temporal and spatial cellular and molecular events in human skin following UV-light exposure (Hall et al., 1993; Pavey et al., 2001; Terui et al., 2001) ;
In this study, several novel observations involving human skin were made including: (1) The initial panepidermal acquisition of thymine dimers induced by UV-light, is followed by a dierential repair response ± such that KCs in the basal layer repaired the DNA damage more rapidly than KCs in upper layers of the epidermis. While the immunostaining-based detection of thymine dimers is not optimal from a quantitative perspective, the UV-light induced DNA damage is rapidly repaired by human epidermal KCs, being nearly complete 24 h after irradiation. (2) The UVlight exposure rapidly induces increased p53 levels throughout the epidermis with preferential early phosphorylation of serine 9 (but not serine 6) residues, followed by serine 15 residues on p53. (3) The induction of p53 was associated with rather limited transcriptional target gene activation, with primary enhancement of p21 and Apaf-1; with little to no changes detectable at either mRNA or protein level for several other p53 target genes, such as Bak, Bax, or GADD45. (4) Despite widespread nuclear accumulation of serine 9 and 15 phosphorylated residues of p53 throughout all cell layers of epidermis, kinetic studies revealed non-random patterns for KC cell death ± namely early apoptosis in the basal layer, followed later by suprabasal layer KCs, followed later still by , and 24 h after exposure to 100 mJ/cm 2 (lanes 2 and 3) to detect pro-caspase 3 and the active form of caspase 9 in the absence of (lane 2) and presence of PFT (lane 3). Note that preincubation of the epidermal equivalent with PFT blocked activation of caspase 3 and caspase 9. b-actin used to verify equivalent protein loading induced apoptosis in which p53 was functionally inactive. (8) A similar death-defying phenotype of psoriatic KCs was also linked to functional inactivation of p53 as neither phosphorylation nor acetylation of various residues was observed.
Traditional models for photocarcinogenesis emphasize a critically important role for p53, not only for its role in growth arrest and DNA surveillance facilitating the repair of DNA damage induced by UV-light; but also for its role beyond the`guardian of the genome' to include`guardian of the tissue' (reviewed in . Current dogma points to a UV-light exposure endpoint of apoptosis by which KCs containing DNA damage are removed from the epidermis in a p53 dependent fashion. Besides these pathways, we suggest another previously overlooked option of KCs exposed to excessive UV-light; which is for the KCs to undergo a`senescent switch' whereby they become irreversibly growth arrested, and develop a resistance to apoptosis . Based on the current in vivo and in vitro results, it appears that senescent KCs are characterized by functional inactivity of p53. From this perspective, loss of p53 function is viewed not necessarily as a pro-carcinogenic event, but as a mechanism by which epidermal KCs preserve structural integrity (and hence barrier formation), while at the same time resists transformation (undergoing irreversible growth arrest i.e. senescence). It should be noted that our ®ndings in which senescent KCs possess functionally inactive p53 are contrasted to the increased activity of p53 observed in senescent ®broblasts (Atadja et al., 1995; Campisi, 2000; Kulja and Lehman, 1995; Webley et al., 2000) . Thus, KCs possess a distinctive genetic program during senescence compared to ®broblasts.
Studies are indicated to determine the molecular basis underlying the inability of senescent KCs to activate p53 in response to UV-light (or other DNA damaging agents such as adriamycin) by failing to phosphorylate or acetylate various amino acid residues on p53. Since immortalized tumorigenic cells share with senescent KCs inactive p53, it is clear that the Figure 9 Characterization of p53 in proliferating and senescent KCs in psoriatic plaques before and after exposure to apoptotic stimuli. Upper panels: Proliferating KCs constitutively express p53, which is enhanced 18 h after exposure to UV-light (30 mJ/ cm 2 ). Following UV-light exposure, proliferating KCs also phosphorylate serine 15 residues and acetylate lysine 382 residues. By contrast, KCs undergoing spontaneous replicative senescence express low levels of p53 which are not phosphorylated or acetylated after UV-light exposure (30 mJ/cm 2 ). Similarly, while proliferating KCs respond to adriamycin exposure by increasing p53-including serine 15 phosphorylation, and lysine 382 acetylation, the senescent KCs do not display signi®cant changes in either p53 levels, and fail to acetylate p53. Lower left panel: DNA binding by p53 is constitutively present and increased in proliferating KCs after UV-light exposure, whereas only minimal DNA binding is observed in senescent KCs either before, or after, UV-light exposure (3 h, 50 mJ/cm 2 ). Positive and negative controls for p53 DNA binding assays are included in lanes a ± d; a: Plabeled p53 consensus DNA binding sequence in presence of anti-p53 mAb. Lower right panels: Western blots reveal no detectable p53 in two dierent normal skin samples (NN skin), but increased p53 levels in two dierent psoriatic plaques (PP skin). Despite elevated p53 in psoriatic plaque, no serine 15 phosphorylation or lysine 382 acetylation was detected. b-actin used to con®rm equal protein loading context in which p53 is silenced is critical to deciphering its role as either promoting or suppressing tumorigenesis. Thus, inactivation of p53 in the majority of cancers occurs by a point mutation. Normal KCs lose p53 activity during senescence by absence of speci®c phosphorylation and acetylation of p53. We suggest that epidermally located KCs possess a distinctive mechanism to regulate p53 activity, which is dierent from other normal cell types such as ®broblasts because of the location of the KCs, and their responsibility in creating and maintaining proper barrier function. Indeed, while ®broblasts clearly depend on intact p53 function for their senescent phenotype (ibid), KCs undergoing senescence are characterized by a loss of p53 function. Also, unlike many other cell types, the range of p53 target genes responding to UV-light and KCs versus ®broblasts is very restrictive. Thus, while ®broblasts undergo or induce a wide assortment of genes (i.e. p21, Bax, Bak, GADD45, etc.), KCs only activate a relatively few number of genes (p21, Apaf-1).
Since Apaf-1 is also a transcriptional target for p53 (Robles et al., 2001) as well as E2F (Moroni et al., 2001) , it is also possible that the second wave of apoptosis in the basal layers 48 h after UV-light exposure results from the dual eects of both p53 and E2F in enhancing Apaf-1 levels. Conversely, the suprabasal layers may be less susceptible to apoptosis because they have undergone growth arrest, with low to absent E2F levels, and hence the ability of p53 to induce Apaf-1 levels to achieve an apoptotic threshold may be mitigated by the paucity or absence of a contribution from the E2F pathway. Further studies are indicated to delineate the p53-related molecular determinants dierentially regulate the growth resistance and sensitivity of KCs that were proliferating or quiescent at the time the skin is exposed to UV-light (Gottifredi et al., 2001; Morris et al., 1997) . The state of dierentiation of KCs may also in¯uence the susceptibility to UV-light induced apoptosis, although murine epidermis in which basal, undierentiated KCs are relatively resistant to apoptosis , we observed in the human skin samples that basal layer KCs were highly susceptible to UV-light induced apoptosis at both 8 and 48 h time points. These dierences highlight the limitations in extrapolating results from rodent skin to human skin.
New therapeutic strategies can be envisioned in preventing or reversing epidermal neoplasms that may involve attempts to target molecular pathways that promote the senescent switch ± which may be achievable even in the absence of functional p53 activity. As we previously demonstrated, targeting p16/ARF appears to be the most likely genes to exploit by this approach . Interestingly, p16 itself appears to be induced in KCs after low dose UV-light exposure, thereby supporting the possibility that such a senescent switch may represent a physiological response of human skin to UV-light (Pavey et al., 2001) . This line of inquiry is bolstered by the results related to psoriatic plaques. Even though KCs within chronic psoriatic plaques resist apoptosis, they almost never transform into squamous cell carcinoma as they contain elevated p16 levels (Nickolo, 2001) . We favor the possibility that triggering a senescent switch in these epidermal cells renders them irreversibly growth arrested, and extend our earlier studies (Wrone-Smith et al., 1995 , 1997 by suggesting their resistance to UVlight induced apoptosis is secondary to the inactivation of the p53 pathway. Studies are underway to determine the mechanism underlying the apoptotic resistance and inability of either senescent KCs or psoriatic KCs to respond to UV-light by phosphorylating and/or acetylating p53.
Finally, while p53 is inactive after the senescence checkpoint is engaged in KCs, further studies are indicated to determine the precise role for p53 in the induction of the senescent phenotype of KCs. Along this line of inquiry, a recent report in which transgenic mice with mutant p53, rendering it constitutively active, were observed to undergo premature aging in several organ systems (Tyner et al., 2002) . Interestingly, while the ®broblast rich dermis became extremely thin with age, the epidermis appeared unremarkable. Thus, in vivo, p53 may play a dierential role in ®broblasts versus KCs as regards the induction of senescence, as well as being dierentially regulated after the senescent checkpoint is engaged.
Materials and methods
Skin samples and epidermal equivalents
All skin specimens (n=6) were obtained from adults undergoing elective plastic surgery (breast reconstruction or abdominoplasty). Normal skin organ cultures were maintained ex vivo by creating small full-thickness tissue fragments, using a scalpel (0.5 ± 1 cm 2 ). These tissue fragments were placed in 10 cm plastic dishes and maintained in culture at an air-liquid interface with DMEM containing antibiotics (100 U/ml penicillin and 100 mg/ml streptomycin), 200 mg/ml glutamine, and 10% fetal bovine serum.
This type of short term organ culture maintains a normal tissue microenvironment and has been used successfully by others to investigate the response of human skin to UV-light (Pavey et al., 1999 (Pavey et al., , 2001 ). Lesions of psoriasis were obtained by performing biopsies of untreated psoriatic plaques (n=5) after informed consent and approval of the Institutional Review Board. Portions of skin were either snap frozen or subjected to protein extraction. Epidermal equivalents were purchased from MatTek Corp. (Ashland, MA, USA). Epidermal equivalents consist of strati®ed and corni®ed layers of human KCs resembling normal human skin when maintained at an air/liquid interface using culture medium provided by the manufacturer (Kubilus et al., 1996) .
Chemical reagents and antibodies
Pi®thrin-hydrobromide (PFT) was obtained from TOCRIS (Ballwin, MO, USA). Anti-human caspase-3 (active) polyclonal antibody used for immunostaining was purchased from R&D System (Minneapolis, MN, USA). Phospho-p53 speci®c antibodies, and antibodies to detect Apaf-1 and activated caspase-9 were obtained from Cell Signaling Technology Inc. (Beverly, MA, USA). Anti-p53 monoclonal antibody (DO-1), anti-p21 polyclonal antibody (C-19), antiBax polyclonal antibody (C-19), anti-Bak polyclonal antibody (N-20), and anti-caspase-3 monoclonal antibody (E8) were all purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Anti-cylobutane pyrimidine dimer (i.e. thymine dimer) antibody (MC-062) was obtained from Kamiya Biomedical Company (Seattle, WA, USA). Antiacetylated p53 lysine 382 (Ab-1) was purchased from Oncogene Research Products (Boston, MA, USA).
UV irradiation and adriamycin treatment
UV irradiations were performed by using a Panelite Unit (Ultralite Enterprise, Inc., Lawrenceville, GA, USA) containing four UVB bulbs (FS36T12/UVB-VHO) as previously described . The output wavelength of the bulbs are 65% UVB, 34% UVA and 1% UVC. The UV dose was monitored with an International Light Inc. radiometer ®tted with a UVB detector. For human skin ex vivo irradiation, skin fragments were exposed with dish lid removed to varying doses of UV light (25, 50, 75 or 100 mJ/cm 2 ) without medium and then was maintained in culture at the air-liquid interface. For epidermal equivalent irradiation, the inserts containing epidermal equivalents were placed in 10 cm dishes irradiated with UV light at 50 or 100 mJ/cm 2 and incubated at the air/liquid interface. In the indicated experiments, epidermal equivalents were exposed to PFT (30 mM) for 16 h prior to UV irradiation. Cells were treated with adriamycin (a topoisomerase II inhibitor that induces double-strand DNA breaks, purchased from Sigma Chemical, St. Louis, MO, USA) for 18 h at 1 mg/ml ®nal concentration.
Epidermal protein extracts and RNA preparations
At the end of the appropriate time of incubation the skin pieces were treated with warmed (608C) PBS for 1 min, and then immediately transferred to ice cold PBS. The epidermis sheet was mechanically separated from the dermis using forceps. To prepare whole cell protein extracts, epidermis sheets were suspended in 1.5 ml eppendo vial with Chaps buer and sonicated for 30 s followed by 30 min vigorously shaking at 48C as previously described . After centrifugation, supernatants were collected and the protein concentration of each sample was determined by Bio-Rad Protein assay reagent. Total epidermis RNA was extracted using Trizol reagent (Life Technologies, Inc.) as previously described (Qin et al., 2001) .
Western blot analysis
Fifty mg of protein were loaded on 10 ± 12% SDS-polyacrylamide gel, transferred to Immunobilon-P membrane and blocked in 5% powdered milk in TBST (50 mM Tris, pH 7.5, 150 mM NaCl, 0.01% Tween 20) as previously described (Kubilus et al., 1996; Qin et al., 1999) . The membrane was incubated with primary antibody (1 : 1000 dilution) overnight at 48C in 2.5% powered milk in TBST and then was washed extensively with 2.5% TBST milk and incubated with 1 : 1500 anti-rabbit or anti-mouse-HRP (Amersham Pharmacia Biotech). Proteins were visualized with the ECL detection kit (Amersham Pharmacia Biotech).
Ribonuclease protection assay
The RNase protection assay was performed according to the manufacturer's instructions (Pharmingen, San Diego, CA, USA). Brie¯y, human stress template set (Riboquant TM ) was labeled with 32 P-uridine triphosphate. Twenty mg RNA and 8610 5 c.p.m. of labeled probe were used for hybridization and after RNase treatment, the protected probes were resolved on 6% urea polyacrylamide gel.
Histological analysis and immunohistochemistry
Samples of human skin or epidermal equivalent samples were ®xed in 10% neutral formalin and processed for histology. Paran sections were stained with hematoxylin and eosin. Paran sections were dewaxed and antigen retrieval using microwaving with citrate buer was performed. Cryostat sections were ®xed in cold acetone and the avidin-biotin peroxidase staining procedure was followed as previously described . Brie¯y, primary antibodies were incubated for 1 h at room temperature, followed by subsequent steps as per the manufacturer's instruction (Vectastain; Vector Laboratories, Burlingame, CA, USA). Positive detection was accomplished using 3-amino-4-ethylcarbazole as chromagen with 1% hematoxylin as the counterstain. For quantitative assessment of KCs staining positive for thymine dimers or activated caspase 3, several sections from each sample were analysed by counting multiple high-power ®elds compressing one linear cm using a calibrated microscope, and the mean+standard error, evaluated for statistical signi®cance using Students t-test. p53 sequence-specific DNA binding using electrophoretic gel mobility-shift assay Nuclear proteins were prepared as described previously . The double-stranded p53 consensus bindingsequence (5'-TAC AGA ACA TGT CTA AGC ATG CTG GGG-3'), and the mutant p53 sequence (5'-TAC AGA ATC GCT CTA AGC ATG CTG GGG-3') were purchased from Santa Cruz Biotechnology, Inc, (CA, USA), the non-mutated oligonucleotide was end-labeled with g-32 P-ATP (Amersham Corp). The binding assay mixture contained 0.5 ng of 32 Plabeled oligonucleotide. Five mg of nuclear extract was combined with 300 ng of calf thymus DNA and adjusted to a ®nal volume of 30 ml with binding buer (20% glycerol, 25 mM HEPES (pH 7.6), 50 mM Kcl, 1 mM DTT, 1 mg/ml bovine serum albumin) with a proteinase inhibitor cocktail (Mannheim, Germany). The binding reaction mixtures were incubated for 30 min at room temperature and loaded onto a 4% non-denaturing polyacrylamide gel and run in 0.256TBE butter at 120 V for 2 h. For supershift analysis, the monoclonal Ab PAb 421 (Oncogene Sciences, Manhasset, NY, USA), which binds to the C terminus of p53 was added (100 ng) to the assays. The gel was then ®xed, vacuum dried, and exposed to Kodak X-ray ®lm.
